[1] Cariello R,Federico A,Sapone A,et al.Intestinal permeability in patients with chronic liver diseases: It's relationship with the aetiology and the entity of liver damage[J].Digestive and Liver Disease,2010,42(3):200-204.
[2] 宋怀宇,姜春华,杨建荣,等.重度慢性乙型肝炎患者肠黏膜通透性的变化及相关因素分析[J].山东医药,2010,50(25):27-28.
[3] Loguercio C,De Simone T,Federico A,et al.Gut-liver axis: a new point of attack to treat chronic liver damage?[J].Am J Gastroenterol,2002,97(8):2144-2146.
[4] 王融冰,刘军民,吴云忠,等.清毒汤治疗肝病肠源性内毒素症临床观察[J].中西医结合肝病杂志,2004,14(3):135-137.
[5] 高连印,车念聪,王融冰,等.清毒汤对TAA致肠源性内毒素血症大鼠肝脏库普弗细胞CD14和清道夫受体表达的影响[J].北京中医药,2011,30(12):947-948.
[6] Nolan JP.The role of intestinal endotoxin in liver injury: a long and evolvinghistory[J].Hepatology,2010,52(5):1829-1835.
[7] Norman K,Pirlich M.Gastrointestinal tract in liver disease: which organ is sick[J].Curr Opin Clin Nutr Metab Care,2008,11(5):613-619.
[8] 刘玉凤.DSS所致的慢性实验性结肠炎加重CCl4诱导的肝纤维化及其机制研究[D].石家庄:河北医科大学,2014.
[9] 林睿.肠黏膜屏障损伤对自身免疫性肝炎患者枯否细胞免疫调节功能影响的研究[D].天津:天津医科大学,2013.
[10] 罗佳佳,曹吴冰,高连印.重型肝炎肠源性内毒素血症的中医药治法初探[J].继续医学教育,2015,29(12):155-156.